Watchlist Manager

Watchlist

Price: 18.37 CNY -0.6% Market Closed

Market Cap: ¥12.2B

S	Shandong Pharmaceutical Glass Co Ltd SSE:600529	CN
	Changsha Broad Homes Industrial Group Co Ltd HKEX:2163	CN
S	StandardAero, Inc. NYSE:SARO	US
R	Rakuten Bank Ltd TSE:5838	JP

Income Statement

Currency: CNY

	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025	Dec-2025
Revenue
Interest Expense	7	0	0	0	11	0	0	0	14	0	0	0	13	0	0	0	10	0	0	0	6	0	0	0	6	0	0	0	5	0	0	0	5	0	0	0	5	0	0	0	4	0	0	0	3	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue	560 N/A	580 +4%	618 +7%	647 +5%	672 +4%	729 +8%	750 +3%	798 +6%	856 +7%	870 +2%	937 +8%	989 +6%	1 012 +2%	1 039 +3%	1 094 +5%	1 161 +6%	1 158 0%	1 174 +1%	1 154 -2%	1 122 -3%	1 242 +11%	1 312 +6%	1 384 +5%	1 443 +4%	1 513 +5%	1 551 +3%	1 550 0%	1 532 -1%	1 397 -9%	1 350 -3%	1 369 +1%	1 390 +2%	1 468 +6%	1 498 +2%	1 514 +1%	1 519 +0%	1 545 +2%	1 577 +2%	1 599 +1%	1 653 +3%	1 691 +2%	1 717 +2%	1 771 +3%	1 771 +0%	1 723 -3%	1 758 +2%	1 801 +2%	1 860 +3%	2 058 +11%	2 182 +6%	2 237 +3%	2 315 +3%	2 331 +1%	2 400 +3%	2 481 +3%	2 547 +3%	2 585 +1%	2 651 +3%	2 720 +3%	2 821 +4%	2 992 +6%	3 042 +2%	3 093 +2%	3 148 +2%	3 427 +9%	3 592 +5%	3 703 +3%	3 921 +6%	3 875 -1%	3 991 +3%	4 040 +1%	4 058 +0%	4 187 +3%	4 382 +5%	4 633 +6%	4 872 +5%	4 982 +2%	5 013 +1%	5 146 +3%	5 133 0%	5 125 0%	5 100 0%	4 913 -4%	4 701 -4%	4 474 -5%
Gross Profit
Cost of Revenue	(352)	(370)	(400)	(421)	(444)	(487)	(504)	(538)	(583)	(594)	(646)	(689)	(716)	(738)	(783)	(838)	(835)	(848)	(824)	(784)	(866)	(910)	(958)	(1 000)	(1 070)	(1 113)	(1 130)	(1 143)	(1 021)	(989)	(1 001)	(1 008)	(1 076)	(1 087)	(1 099)	(1 104)	(1 128)	(1 151)	(1 165)	(1 211)	(1 252)	(1 259)	(1 290)	(1 264)	(1 197)	(1 214)	(1 223)	(1 261)	(1 409)	(1 517)	(1 564)	(1 604)	(1 592)	(1 642)	(1 675)	(1 709)	(1 678)	(1 697)	(1 729)	(1 800)	(1 902)	(1 963)	(1 999)	(2 006)	(2 307)	(2 505)	(2 621)	(2 864)	(2 754)	(2 840)	(2 898)	(2 927)	(3 087)	(3 306)	(3 477)	(3 606)	(3 615)	(3 568)	(3 617)	(3 599)	(3 556)	(3 540)	(3 424)	(3 229)	(3 087)
Gross Profit	208 N/A	210 +1%	218 +4%	226 +4%	228 +1%	242 +6%	247 +2%	260 +5%	272 +5%	276 +1%	291 +5%	299 +3%	296 -1%	301 +2%	311 +3%	323 +4%	323 0%	326 +1%	330 +1%	338 +2%	376 +11%	403 +7%	426 +6%	443 +4%	444 +0%	439 -1%	420 -4%	389 -7%	376 -3%	361 -4%	369 +2%	382 +4%	392 +3%	411 +5%	416 +1%	415 0%	417 +0%	427 +2%	435 +2%	442 +2%	439 -1%	458 +4%	481 +5%	507 +5%	526 +4%	544 +4%	578 +6%	600 +4%	648 +8%	664 +2%	672 +1%	711 +6%	739 +4%	758 +3%	806 +6%	838 +4%	907 +8%	955 +5%	990 +4%	1 021 +3%	1 090 +7%	1 079 -1%	1 095 +1%	1 142 +4%	1 120 -2%	1 087 -3%	1 083 0%	1 057 -2%	1 121 +6%	1 151 +3%	1 142 -1%	1 132 -1%	1 101 -3%	1 075 -2%	1 156 +8%	1 266 +9%	1 367 +8%	1 445 +6%	1 529 +6%	1 534 +0%	1 570 +2%	1 560 -1%	1 489 -5%	1 471 -1%	1 387 -6%
Operating Income
Operating Expenses	(89)	(86)	(90)	(94)	(97)	(106)	(106)	(111)	(120)	(120)	(129)	(137)	(132)	(132)	(143)	(150)	(176)	(174)	(178)	(184)	(198)	(212)	(219)	(224)	(236)	(233)	(227)	(211)	(231)	(228)	(236)	(248)	(228)	(245)	(249)	(248)	(241)	(258)	(263)	(275)	(268)	(283)	(304)	(315)	(320)	(343)	(353)	(369)	(381)	(406)	(408)	(427)	(428)	(411)	(455)	(485)	(497)	(543)	(529)	(522)	(558)	(524)	(525)	(509)	(448)	(390)	(366)	(336)	(429)	(463)	(448)	(461)	(429)	(417)	(439)	(451)	(512)	(533)	(561)	(551)	(530)	(523)	(576)	(639)	(543)
Selling, General & Administrative	(93)	(88)	(91)	(95)	(98)	(105)	(105)	(109)	(113)	(116)	(120)	(129)	(128)	(129)	(144)	(149)	(165)	(168)	(172)	(182)	(188)	(204)	(209)	(211)	(220)	(217)	(211)	(198)	(216)	(215)	(221)	(233)	(205)	(218)	(218)	(219)	(219)	(230)	(236)	(246)	(241)	(267)	(285)	(286)	(297)	(293)	(303)	(314)	(342)	(324)	(335)	(342)	(338)	(369)	(395)	(423)	(398)	(437)	(412)	(396)	(417)	(406)	(407)	(393)	(301)	(237)	(213)	(191)	(281)	(317)	(292)	(302)	(264)	(256)	(280)	(293)	(359)	(370)	(373)	(365)	(365)	(325)	(353)	(376)	(324)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(2)	0	0	0	(2)	0	0	0	(3)	0	0	0	(4)	0	0	0	(17)	0	0	(30)	(75)	0	0	(19)	(71)	(68)	(106)	(127)	(116)	(127)	(121)	(121)	(123)	(143)	(144)	(137)	(121)	(133)	(137)	(138)	(118)	(136)	(132)	(128)	(119)	(147)	(153)	(160)	(132)	(162)	(170)	(175)	(150)
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(20)	0	0	0	(19)	0	0	0	(22)	0	0	0	(18)	0	0	0	(20)	0	0	0	(19)	0	0	0	(33)	0	0	0	(32)	0	0	0	(36)	0	0	0	(41)	0	0	0	(57)	0	0	0	(53)	0	0	0	(56)	0	0	0	(88)
Other Operating Expenses	4	2	1	1	1	(1)	(1)	(2)	(7)	(4)	(9)	(8)	(4)	(2)	1	(1)	(11)	(6)	(6)	(3)	(10)	(8)	(9)	(13)	(17)	(17)	(16)	(13)	(15)	(14)	(14)	(15)	(2)	(27)	(31)	(29)	(2)	(28)	(27)	(30)	(2)	(15)	(19)	(29)	(2)	(50)	(50)	(55)	(2)	(82)	(73)	(54)	4	(42)	(60)	(43)	6	(38)	(11)	1	8	8	3	5	12	(9)	(10)	(9)	15	(13)	(19)	(21)	10	(24)	(28)	(31)	20	(16)	(36)	(27)	23	(36)	(53)	(88)	19
Operating Income	119 N/A	124 +5%	128 +3%	132 +3%	131 0%	136 +4%	141 +4%	149 +6%	152 +2%	156 +3%	162 +4%	163 +0%	165 +1%	169 +3%	168 -1%	173 +3%	147 -15%	152 +3%	152 0%	154 +1%	179 +16%	191 +7%	207 +9%	220 +6%	207 -6%	206 -1%	193 -6%	178 -8%	146 -18%	133 -9%	133 0%	134 +1%	164 +22%	166 +1%	167 +1%	167 +0%	176 +5%	169 -4%	171 +1%	167 -3%	172 +3%	175 +2%	177 +1%	192 +9%	206 +7%	202 -2%	225 +12%	231 +3%	268 +16%	259 -3%	264 +2%	284 +8%	311 +9%	347 +12%	351 +1%	354 +1%	410 +16%	412 +0%	462 +12%	499 +8%	532 +7%	555 +4%	570 +3%	632 +11%	672 +6%	697 +4%	716 +3%	720 +1%	692 -4%	688 -1%	694 +1%	671 -3%	672 +0%	659 -2%	717 +9%	815 +14%	855 +5%	912 +7%	967 +6%	983 +2%	1 040 +6%	1 037 0%	913 -12%	832 -9%	844 +1%
Pre-Tax Income
Interest Income Expense	(4)	(6)	(8)	(9)	(10)	(12)	(13)	(15)	(15)	(15)	(12)	(10)	(5)	(3)	(5)	(6)	(5)	(10)	(2)	(0)	(1)	(2)	(8)	(9)	(4)	(5)	(0)	2	2	1	(3)	(4)	(4)	(8)	(10)	(11)	(9)	(9)	(6)	(5)	(1)	(2)	(0)	2	8	8	8	10	20	19	18	15	5	(10)	20	52	60	75	58	45	51	57	52	28	14	2	(6)	6	17	10	34	48	52	59	68	60	80	85	73	70	77	68	60	58	46
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(6)	0	0	0	(6)	0	0	0	0	0	0	0	(16)	0	0	0	(33)	0	0	0	(6)	1	1	1	(22)	(1)	2	2	4	3	0	(0)	(36)	(0)	(0)	0	(11)	1	1	1	(12)	4	5	4	(19)	(6)	(6)	(5)	(5)	0	0	1	(52)
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	(7)	0	0	0	(1)	0	0	0	0	0	0	0	(1)	0	0	0	(1)	0	0	0	(2)	0	0	0	(7)	0	0	0	0	0	0	0	0	0	0	0	(21)	0	0	0	(44)	0	(8)	0	0	0	0	0	(23)	0	0	0	(8)	0	0	0	(7)	0	0	0	(2)	0	0	0	(6)
Total Other Income	(0)	0	(0)	(0)	0	(0)	0	1	3	4	4	6	4	5	7	5	17	17	15	12	2	(7)	(6)	(3)	5	8	8	3	19	16	18	21	8	6	7	8	4	3	1	0	0	(2)	(2)	(4)	5	(5)	(15)	(16)	(15)	(13)	(3)	0	1	(5)	(22)	(25)	0	(23)	(31)	(22)	4	(41)	(14)	(26)	3	(21)	(12)	(16)	14	(13)	(13)	(6)	5	1	(7)	(17)	1	(6)	(2)	4	(0)	(2)	(3)	(4)	(1)
Pre-Tax Income	115 N/A	119 +4%	119 +1%	122 +3%	121 -1%	124 +2%	128 +3%	135 +6%	141 +4%	145 +3%	154 +6%	158 +3%	165 +4%	171 +4%	170 -1%	172 +1%	159 -7%	159 N/A	165 +4%	165 +0%	173 +5%	183 +6%	193 +6%	208 +7%	207 0%	208 +1%	200 -4%	183 -9%	167 -9%	151 -10%	148 -2%	151 +2%	160 +6%	164 +3%	164 0%	164 +0%	164 +0%	164 0%	166 +1%	161 -3%	168 +4%	171 +1%	175 +2%	189 +8%	195 +3%	204 +5%	218 +7%	225 +3%	239 +6%	265 +11%	280 +6%	299 +7%	310 +4%	333 +7%	350 +5%	382 +9%	428 +12%	462 +8%	490 +6%	523 +7%	546 +4%	574 +5%	599 +4%	635 +6%	654 +3%	678 +4%	699 +3%	712 +2%	689 -3%	687 0%	716 +4%	714 0%	708 -1%	723 +2%	783 +8%	862 +10%	911 +6%	986 +8%	1 033 +5%	1 052 +2%	1 111 +6%	1 103 -1%	970 -12%	887 -9%	831 -6%
Net Income
Tax Provision	(39)	(40)	(41)	(41)	(38)	(39)	(37)	(40)	(45)	(45)	(49)	(50)	(50)	(46)	(39)	(36)	(24)	(23)	(26)	(27)	(28)	(29)	(30)	(32)	(35)	(41)	(39)	(39)	(34)	(30)	(36)	(37)	(41)	(41)	(40)	(38)	(42)	(43)	(43)	(45)	(45)	(45)	(46)	(49)	(51)	(54)	(60)	(64)	(50)	(49)	(42)	(38)	(48)	(50)	(52)	(56)	(69)	(77)	(82)	(86)	(87)	(91)	(96)	(103)	(89)	(94)	(96)	(92)	(98)	(99)	(104)	(98)	(90)	(92)	(101)	(125)	(135)	(156)	(167)	(170)	(168)	(158)	(131)	(122)	(141)
Income from Continuing Operations	76	78	79	81	83	85	90	95	96	100	105	108	115	125	130	136	135	136	138	138	145	153	164	176	172	167	162	144	133	121	112	115	120	124	124	126	122	121	123	117	124	126	129	140	145	151	158	161	189	215	237	261	263	283	298	326	358	386	409	437	459	484	503	532	564	585	603	620	591	588	612	616	618	632	682	738	776	830	865	882	943	946	839	765	690
Income to Minority Interest	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(1)	(0)	(1)	(1)	(0)	(0)	(0)	0	(0)	(0)	(1)	(1)	(0)	(0)	(1)	(1)	(1)	(1)	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income (Common)	76 N/A	78 +3%	79 +0%	81 +4%	83 +1%	84 +2%	90 +7%	95 +5%	96 +1%	100 +4%	104 +5%	108 +4%	115 +6%	125 +9%	130 +4%	136 +4%	135 -1%	136 +1%	138 +2%	138 +0%	144 +4%	153 +6%	164 +7%	176 +7%	171 -3%	167 -3%	161 -3%	144 -11%	133 -8%	121 -9%	112 -7%	115 +2%	120 +5%	124 +3%	124 +0%	126 +2%	122 -3%	121 -1%	123 +1%	117 -4%	125 +6%	127 +2%	130 +2%	141 +8%	145 +3%	152 +4%	159 +5%	162 +2%	190 +17%	216 +14%	237 +10%	261 +10%	263 +1%	283 +8%	298 +5%	326 +9%	358 +10%	386 +8%	409 +6%	437 +7%	459 +5%	484 +5%	503 +4%	532 +6%	564 +6%	585 +4%	603 +3%	620 +3%	591 -5%	588 -1%	612 +4%	616 +1%	618 +0%	632 +2%	682 +8%	738 +8%	776 +5%	830 +7%	865 +4%	882 +2%	943 +7%	946 +0%	839 -11%	765 -9%	690 -10%
EPS (Diluted)	0.17 N/A	0.18 +6%	0.18 N/A	0.19 +6%	0.19 N/A	0.2 +5%	0.21 +5%	0.22 +5%	0.22 N/A	0.22 N/A	0.22 N/A	0.22 N/A	0.23 +5%	0.24 +4%	0.25 +4%	0.26 +4%	0.27 +4%	0.27 N/A	0.28 +4%	0.28 N/A	0.29 +4%	0.31 +7%	0.33 +6%	0.35 +6%	0.34 -3%	0.33 -3%	0.32 -3%	0.29 -9%	0.26 -10%	0.25 -4%	0.23 -8%	0.24 +4%	0.24 N/A	0.25 +4%	0.25 N/A	0.25 N/A	0.24 -4%	0.24 N/A	0.24 N/A	0.23 -4%	0.25 +9%	0.24 -4%	0.25 +4%	0.27 +8%	0.29 +7%	0.3 +3%	0.31 +3%	0.32 +3%	0.38 +19%	0.36 -5%	0.39 +8%	0.43 +10%	0.44 +2%	0.48 +9%	0.5 +4%	0.55 +10%	0.6 +9%	0.65 +8%	0.69 +6%	0.74 +7%	0.77 +4%	0.82 +6%	0.85 +4%	0.9 +6%	0.95 +6%	0.98 +3%	1.01 +3%	1.04 +3%	0.99 -5%	0.99 N/A	1.03 +4%	1.04 +1%	0.93 -11%	0.95 +2%	1.02 +7%	1.11 +9%	1.17 +5%	1.25 +7%	1.3 +4%	1.33 +2%	1.42 +7%	1.43 +1%	1.26 -12%	1.15 -9%	1.04 -10%

Income Statement Balance Sheet Cash Flow Statement

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Income Statement

Earnings Waterfall
Shandong Pharmaceutical Glass Co Ltd

Income Statement
Shandong Pharmaceutical Glass Co Ltd

See Also

Company

Help

Tools

Stocks

Shandong Pharmaceutical Glass Co Ltd SSE:600529

Income Statement

Earnings Waterfall Shandong Pharmaceutical Glass Co Ltd

Income Statement Shandong Pharmaceutical Glass Co Ltd

See Also

Company

Help

Tools

Stocks

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Earnings Waterfall
Shandong Pharmaceutical Glass Co Ltd

Income Statement
Shandong Pharmaceutical Glass Co Ltd